ITUS Corporation Licenses CAR-T Technology from The Wistar InstituteMarkets InsiderSAN JOSE, Calif., Nov. 14, 2017 /PRNewswire/ — ITUS Corporation (NASDAQ: ITUS) today announced that it has executed an exclusive worldwide license agreement with The Wi… Continue reading
ITUS Corporation Licenses CAR-T Technology from The Wistar InstitutePR Newswire (press release)SAN JOSE, Calif., Nov. 14, 2017 /PRNewswire/ — ITUS Corporation (NASDAQ: ITUS) today announced that it has executed an exclusive worldwide license agreement… Continue reading
Chemical & Engineering News |
Torque launches with $25 million in funding to arm immune cells
Chemical & Engineering News Torque joins a legion of companies tinkering with immune cells so they can find and attack cancer cells. In August, the U.S. Food & Drug Administration approved the first chimeric antigen receptor (CAR) T-cell therapy, Novartis’ Kymriah, to treat kids … Torque takes tumor tech out of stealth with $25M backing, new CEOEndpoints News Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell …Markets Insider |
Labiotech.eu (blog) |
British Biotech Gets a £2.5M Grant to Boost Cancer Immunotherapy
Labiotech.eu (blog) Tusk Therapeutics is working on immunotherapies to ignite the immune system against cancer. The £2.5M grant will help it to accelerate their development. Tusk Therapeutics focuses on immuno-oncology to ‘harness the power’ of the immune system. One of … |
The Express Tribune |
With genetic engineering and hubris, these biology Olympians compete to improve on nature
STAT OSTON — If there is one point of agreement among the 300 teams from 42 countries that participated in this year’s synthetic biology Olympics in Boston, it is probably this: The microbes that nature made are a good starting point, but we can do better. Pakistani team bag silver medal at iGEM 2017The Express Tribune |